Literature DB >> 8658014

Integrin signaling and matrix assembly.

E Ruoslahti1.   

Abstract

Cell adhesion and migration are controlled by the level of alpha 5 beta 1 integrin (fibronectin receptor) and by the amount of fibronectin matrix around the cell; adhesion is promoted at all levels of integrin expression and matrix assembly, whereas high levels of either or both curb cell migration. The alpha 5 beta 1 integrin appears to be a growth-suppressing integrin, and it protects cells from apoptosis when growth factors are absent. In contrast, the alpha v beta 3 integrin (vitronectin receptor) cooperates with certain growth factors, potentiating their effect on cells. These effects of alpha 5 beta 1 and alpha v beta 3 depend on signaling pathways specific for these integrins; integrins have both common and specific pathways for signaling into the cell. Moreover, integrins require activation from the inside of the cell to be able to bind their ligand outside the cell. High alpha 5 beta 1 expression and abundant matrix formation also suppress tumorigenicity in vivo, whereas perturbing the function of alpha 5 beta 1 with peptides that block its ligand binding suppresses experimental metastasis. Effecting these changes in tumor cells by gene therapy or pharmacological approaches may provide useful new cancer therapies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8658014     DOI: 10.1159/000217975

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Integrin subunit gene expression is regionally differentiated in adult brain.

Authors:  J K Pinkstaff; J Detterich; G Lynch; C Gall
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

Review 2.  Regulation of integrin functions by N-glycans.

Authors:  Jianguo Gu; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Dentin phosphoprotein (DPP) activates integrin-mediated anchorage-dependent signals in undifferentiated mesenchymal cells.

Authors:  Asha Eapen; Amsaveni Ramachandran; Anne George
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

4.  Rap1GAP regulates renal cell carcinoma invasion.

Authors:  Wan-Ju Kim; Zachary Gersey; Yehia Daaka
Journal:  Cancer Lett       Date:  2012-01-20       Impact factor: 8.679

5.  Low α(2)β(1) integrin function enhances the proliferation of fibroblasts from patients with idiopathic pulmonary fibrosis by activation of the β-catenin pathway.

Authors:  Hong Xia; Jeremy Seeman; Jian Hong; Polla Hergert; Vidya Bodem; Jose Jessurun; Karen Smith; Richard Nho; Judy Kahm; Philippe Gaillard; Craig Henke
Journal:  Am J Pathol       Date:  2012-05-27       Impact factor: 4.307

6.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

7.  Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells.

Authors:  Pingtao Tang; Marina Jerebtsova; Ronald Przygodzki; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

8.  Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Authors:  Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David Tice; Anil K Sood
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Integrin affinity modulation in angiogenesis.

Authors:  Ganapati H Mahabeleshwar; Juhua Chen; Weiyi Feng; Payaningal R Somanath; Olga V Razorenova; Tatiana V Byzova
Journal:  Cell Cycle       Date:  2007-11-01       Impact factor: 4.534

10.  Beta1-integrin signaling is essential for lens fiber survival.

Authors:  Andrew R Samuelsson; Richard Belvindrah; Chuanyue Wu; Uli Müller; Willi Halfter
Journal:  Gene Regul Syst Bio       Date:  2007-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.